Last checked at 12 Oct 2023 07:00
Tristel plc
("Tristel" or the "Company")
Additional Investor Presentation
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the Company will deliver a Company Overview presentation at a hybrid event in London hosted by the UK Individual Shareholders' Society (ShareSoc) on Thursday 19 October 2023 and available to ShareSoc members via the link below:
https://www.sharesoc.org/sharesoc-walbrook-pr-healthcare-companies-hybrid-event-london-19-october-2023-5pm/
Paul Swinney, Chief Executive Officer will deliver an "in-person" presentation which will also be streamed live (and recorded), allowing ShareSoc members to watch virtually.
Preliminary results for the year ended 30 June 2023 will be announced on Monday 16 October 2023 and no new material information will be disclosed in the presentation.
As previously announced the Company will also provide both an online presentation and in-person presentation open to all interested investors on Monday 16 October 2023. Further details can be found here:
https://tristelgroup.com/wp-content/uploads/2023/09/TSTL-Notice-of-results-FINAL.pdf
For further information please contact:
Tristel plc | Tel: 01638 721 500 | |
Paul Swinney, Chief Executive Officer | ||
Liz Dixon, Chief Financial Officer | ||
| ||
Walbrook PR Ltd | Tel: 020 7933 8780 or tristel@walbrookpr.com | |
Paul McManus | Mob: 07980 541 893 | |
Lianne Applegarth | Mob: 07584 391 303 | |
Charlotte Edgar | Mob: 07884 664 686 | |
Cavendish Capital Markets Limited | Tel: 020 7220 0500 | |
Geoff Nash/Charlie Beeson (Corporate Finance) | ||
Sunila de Silva (ECM) | ||